We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-12.67%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$586M
AUM Growth
-$197M
(-25%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-9.71%
Top 10 Holdings %
Top 10 Hldgs %
50.11%
Holding
80
New
11
Increased
14
Reduced
24
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
+$35.1M |
| 2 |
PFNX
Pfenex Inc.
PFNX
|
+$25.7M |
| 3 |
CareDx
CDNA
|
+$24.3M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$14.1M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$37.1M |
| 2 |
MODN
MODEL N, INC.
MODN
|
+$30.2M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$26.4M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$24.1M |
| 5 |
NeoGenomics
NEO
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.23% |
| 2 | Communication Services | 3.51% |
| 3 | Industrials | 1.19% |
| 4 | Energy | 0.34% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
KORU Medical Systems
KRMD
$189M
| $54.3M | 9.27% |
7,238,592
+20,578
| +0.3% | +$138K |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $37.5M | 6.4% |
4,050,040
-31,015
| -0.8% | -$433K |
|
|
SPNE
3
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $36.7M | 6.26% |
4,489,553
+2,663,149
| +146% | +$35.1M |
|
4
Halozyme
HALO
$9.79B
| $29.3M | 5.01% |
1,630,591
-70,191
| -4% | -$1.33M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $27.2M | 4.64% |
2,017,103
+771,860
| +62% | +$13M |
|
6
AtriCure
ATRC
$1.92B
| $25.2M | 4.31% |
750,818
-361,880
| -33% | -$13M |
|
|
7
CareDx
CDNA
$2.26B
| $23.7M | 4.05% |
+1,085,752
| New | +$24.3M |
|
|
PFNX
8
DELISTED
Pfenex Inc.
PFNX
| $20.6M | 3.52% |
+2,339,671
| New | +$25.7M |
|
|
MODN
9
DELISTED
MODEL N, INC.
MODN
| $20.6M | 3.51% |
925,921
-1,034,804
| -53% | -$30.2M |
|
10
Tandem Diabetes Care
TNDM
$1.34B
| $18.4M | 3.14% |
286,191
+17,617
| +7% | +$1.23M |
|
|
VAPO
11
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $17.5M | 2.99% |
116,262
-27,114
| -19% | -$2.45M |
|
|
XENT
12
DELISTED
Intersect ENT, Inc
XENT
| $17.2M | 2.94% |
1,453,729
+254,560
| +21% | +$5.64M |
|
13
iShares US Medical Devices ETF
IHI
$3.13B
| $17.1M | 2.92% |
45,480
| – | – |
|
|
14
NeoGenomics
NEO
$1.96B
| $16.9M | 2.88% |
610,664
-726,285
| -54% | -$21.8M |
|
15
Codexis
CDXS
$151M
| $16.6M | 2.83% |
1,486,598
+300,485
| +25% | +$4.2M |
|
16
Teva Pharmaceuticals
TEVA
$40.8B
| $16.6M | 2.83% |
1,843,246
+187,075
| +11% | +$1.92M |
|
17
Insmed
INSM
$21.4B
| $16.3M | 2.79% |
1,019,737
-273,811
| -21% | -$6.49M |
|
|
18
Iovance Biotherapeutics
IOVA
$1.82B
| $15.9M | 2.71% |
+530,805
| New | +$14.1M |
|
19
Ultragenyx Pharmaceutical
RARE
$2.45B
| $15.2M | 2.6% |
342,603
+168,166
| +96% | +$8.73M |
|
20
United Therapeutics
UTHR
$25.8B
| $12.2M | 2.08% |
+128,509
| New | +$12.2M |
|
|
ALXN
21
DELISTED
Alexion Pharmaceuticals
ALXN
| $11M | 1.88% |
122,645
+96,361
| +367% | +$9.46M |
|
22
Ionis Pharmaceuticals
IONS
$8.6B
| $9.26M | 1.58% |
195,850
-47,841
| -20% | -$2.67M |
|
23
BioMarin Pharmaceuticals
BMRN
$11.6B
| $8.89M | 1.52% |
105,157
+3,647
| +4% | +$314K |
|
24
Heron Therapeutics
HRTX
$93.9M
| $8.12M | 1.39% |
691,400
-389,759
| -36% | -$7.33M |
|
25
SI-BONE Inc
SIBN
$788M
| $8.11M | 1.38% |
678,773
-6,358
| -0.9% | -$117K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, First Light Asset Management held 80 positions worth $586M, down 25% from $782M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
First Light Asset Management withdrew a net $56.9M in Q1 2020, closing 16 positions and reducing 24 holdings. Its most notable exit was Omnicell, an estimated $37.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 73% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, First Light Asset Management opened a new position in Pfenex Inc. worth $20.6M.
- First Light Asset Management's largest Q1 2020 buy was Pfenex Inc.: 2,339,671 shares worth $20.6M.
- First Light Asset Management added most to SeaSpine Holdings Corporation Common Stock in Q1 2020, an estimated $35.1M increase.
- First Light Asset Management's biggest Q1 2020 reduction was MODEL N, INC., cutting an estimated $30.2M.
- First Light Asset Management fully exited Omnicell in Q1 2020, selling an estimated $37.1M.
- First Light Asset Management's ten largest holdings make up 50% of its $586M portfolio in Q1 2020.
- First Light Asset Management opened 11 new positions and closed 16 in Q1 2020.
- First Light Asset Management's portfolio value fell 25% quarter-over-quarter to $586M.
Based on First Light Asset Management's 13F filing for Q1 2020, filed 15 May 2020.